Celine Anquetil
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
VEGF-A blockade overcomes liver metastases resistance to chemoimmunotherapy in patients with advanced non-squamous NSCLC.
Journal: Journal for immunotherapy of cancer
Published: May 05, 2026
Bulk δ13C tracks UV-induced aging of 200-nm polystyrene particles: effects of formulation and particle concentration.
Journal: Environmental pollution (Barking, Essex : 1987)
Published: March 25, 2026
Impact of the francophone pediatric intensive care group bronchiolitis recommendations on diagnostic testing, antibiotic therapy and patient prognosis.
Journal: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
Published: January 08, 2025
Ultrasensitive interferons quantification reveals different cytokine profile secretion in inflammatory myopathies and can serve as biomarkers of activity in dermatomyositis.
Journal: Frontiers in immunology
Published: November 17, 2024
Features of myositis and myasthenia gravis in patients treated with immune checkpoint inhibitors: a multicentric, retrospective cohort study.
Journal: The Lancet regional health. Europe
Published: July 10, 2024
Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity.
Journal: Neuropathology and applied neurobiology
Published: February 07, 2022
JAK inhibitors for the treatment of adult dermatomyositis: A pilot study.
Journal: Journal of the American Academy of Dermatology
Published: December 30, 2021
MRI and muscle imaging for idiopathic inflammatory myopathies.
Journal: Brain pathology (Zurich, Switzerland)
Published: February 22, 2021
The role of interferons type I, II and III in myositis: A review.
Journal: Brain pathology (Zurich, Switzerland)
Published: February 16, 2021
Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance.
Journal: Annual review of pharmacology and toxicology
Published: September 02, 2020
Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities.
Journal: Autoimmunity reviews
Published: February 08, 2020
Last Updated: 09/26/2026